Abstract
In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic neurons in the substantia nigra pars compacta (SNc) is associated with classic motor features, which typically have a focal onset. Since a defined somatotopic arrangement in the SNc has not been recognized, this focal motor onset is unexplained and hardly justified by current pathogenic theories of bottom-up disease progression (Braak's hypothesis, prionopathy). Here we propose that corticostriatal activity may represent a critical somatotopic "stressor" for nigrostriatal terminals, ultimately driving retrograde nigrostriatal degeneration and leading to focal motor onset and progression of Parkinson's disease. As a pathogenic mechanism, corticostriatal activity may promote secretion of striatal extracellular alpha-synuclein, favoring its pathological aggregation at vulnerable dopaminergic synapses. A similar pathogenic process may occur at corticofugal projections to the medulla oblongata and other vulnerable structures, thereby contributing to the bottom-up progression of Lewy pathology. This cortical pathogenesis may co-exist with bottom-up mechanisms, adding an integrative top-down perspective to the quest for the factors that impinge upo...Continue Reading
Citations
Mar 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B Postuma, Daniela Berg
Feb 14, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Nico J DiederichChristopher G Goetz
Jul 28, 2019·Cells·Leonardo AcuñaRita Raisman-Vozari
Aug 15, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Guglielmo FoffaniJosé A Obeso
Feb 8, 2020·Journal of Neural Transmission·Jelena Osmanovic BarilarMelita Salkovic-Petrisic
Mar 13, 2020·Schizophrenia Bulletin·Robert C WolfDusan Hirjak
May 13, 2020·Fortschritte der Neurologie-Psychiatrie·Peter UrbanChristian Winkler
Apr 2, 2020·Molecular Neurodegeneration·Meir SchechterRonit Sharon
Jun 9, 2020·Brain Communications·Sarah MacIsaacAusten J Milnerwood
Sep 29, 2020·Frontiers in Neurology·Maria Marcella LaganàFrancesca Baglio
Sep 26, 2020·Frontiers in Molecular Neuroscience·Naila Kuhlmann, Austen J Milnerwood
Nov 4, 2020·Brain : a Journal of Neurology·Claudia AmmannGuglielmo Foffani
Dec 12, 2020·Journal of the International Neuropsychological Society : JINS·Iván GaltierJosé Barroso
Jan 21, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Mariana H G MonjeJosé A Obeso
Jan 30, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Seong Ho JeongPhil Hyu Lee
Feb 20, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Fadi AeedYitzhak Schiller
Mar 7, 2021·Cells·Gordon W Arbuthnott
Mar 20, 2021·Frontiers in Cellular Neuroscience·Nolwazi Z GcwensaLaura A Volpicelli-Daley
Apr 4, 2021·Cells·Jeswinder Sian-Hulsmann, Peter Riederer
Feb 10, 2021·Harvard Review of Psychiatry·Alan A Baumeister
May 11, 2021·Frontiers in Synaptic Neuroscience·Tamara KobiecSantiago Pérez-Lloret
Jul 22, 2021·NPJ Parkinson's Disease·Adithya GopinathHabibeh Khoshbouei
Sep 18, 2021·Molecular Brain·Chelsie A KadgienAusten J Milnerwood
Oct 13, 2021·Journal of Neural Transmission·P RiedererJ Sian-Hülsmann
Aug 13, 2021·Brain : a Journal of Neurology·Rick C Helmich, Stéphane Lehéricy
Nov 19, 2021·Experimental Neurology·Susanne KnorrChi Wang Ip
Jan 12, 2022·PloS One·Roger Pamphlett, David P Bishop